Journal
CANCER RESEARCH AND TREATMENT
Volume 41, Issue 1, Pages 1-11Publisher
KOREAN CANCER ASSOCIATION
DOI: 10.4143/crt.2009.41.1.1
Keywords
Nanoparticels; Cancer therapy; Drug delivery
Categories
Funding
- National Cancer Institute (NCI) Specialized Program of Research Excellence (SPORE) grant [P50CA128613]
- Centers of Cancer Nanotechnology Excellence (CCNE) grant [U54 CA119338]
- NATIONAL CANCER INSTITUTE [U54CA119338, P50CA128613] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient drug targeting and delivery. Clinical investigations suggest that therapeutic nanoparticles can enhance efficacy and reduced side effects compared with conventional cancer therapeutic drugs. Encouraged by rapid and promising progress in cancer nanotechnology, researchers continue to develop novel and efficacious nanoparticles for drug delivery. The use of therapeutic nanoparticles as unique drug delivery systems will be a significant addition to current cancer therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available